Latest Clinical Evidence Presented at SAWC 2021 Illustrates the Significant Clinical Utility of the MolecuLight Point-of-Care Imaging Platform Protection Status
Blog Category: 

By Industry News

Toronto, ONTARIO and Las Vegas, NEVADA– (October 28, 2021) MolecuLight Inc., a provider of in point-of-care fluorescence imaging for the detection of wounds that contain elevated bacterial loads, announces the presentation of 7 clinical posters and presentations at the Symposium of Wound Care (SAWC) Fall 2021, held from October 29 – 31, 2021 in Las Vegas, Nevada.

“We are thrilled to have so many customers presenting their impressive clinical findings at this year’s SAWC Fall conference”, says Anil Amlani, MolecuLight’s CEO. "The clinical topics being presented span the wound care continuum, from improved wound assessment and treatment planning, to monitoring of wound cleaning and debridement efficacy, and the resulting improvement in wound healing rates. Presenters will also describe detection and treatment of wound-related cellulitis, and findings from the recently published Delphi consensus-based guidelines for the use of the MolecuLight platform. The outcomes presented in these studies illustrate the significant clinical improvements to wound care provided to clinicians by the MolecuLight i:X.”

A submission on MolecuLight by Dr. Charles A. Andersen was one of the top scoring abstracts out of more than 200 submissions. This is the fifth consecutive SAWC meeting at which an abstract on improved patient care achieved through use of the MolecuLight i:X has received this honour.

The 5 clinical posters and 2 presentations featuring the MolecuLight i:X from SAWC Fall 2021 are as follows:

12-Week RCT Evaluating Impact of Routine Fluorescence Imaging of Bacteria on DFU Healing Rates
Alisha Oropallo, MD, Scott Gawlik DPM, Dean Vayser, MD

Cleansing Techniques for Wound Hygiene: Which Are Most Effective?
Alisha Oropallo, MD, Amit Rao MD, Jai Joshi

Detection of bacterial fluorescence from in vivo wound biofilms using a point-of-care fluorescence imaging device
Andrea J. Lopez, Laura M. Jones, Landrye Reynolds, Rachel C. Diaz, Isaiah K. George, William Little, Derek Fleming, Anna D'souza, Kendra Rumbaugh, Allie Clinton Smith, Monique Y. Rennie

Are Semi-quantitative Clinical Cultures Inadequate? Comparison to Quantitative Analysis of 1053 Bacterial Isolates from 350 Wounds
Thomas E. Serena, Phil Bowler, Gregory Schultz, Anna D’souza, Monique Rennie

Guidelines for point-of-care fluorescence imaging for detection of wound bacterial burden based on Delphi consensus
Charles A. Andersen, Alisha R. Oropallo, Raymond Abdo, Jenny Hurlow, Martha R Kelso, M. Mark Melin and Thomas E. Serena

Diagnosis and Treatment of the Invasive Extension of Bacteria (Cellulitis) from Chronic Wounds Utilizing Point-of-Care Fluorescence Imaging
Charles Andersen, Katherine McLeod, Rowena Steffan

Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care
Charles Andersen

In additional to the clinical posters and presentations at SAWC (Symposium on Advanced Wound Care) Fall 2021, the recently launched MolecuLightDX will be available for demonstration in the MolecuLight booth #439 in the Exhibit Hall at Caesars Palace in Las Vegas, Nevada.

About MolecuLight Inc.

MolecuLight is the manufacturer of MolecuLight i:X®, a point-of-care fluorescence imaging device for digital wound measurement and detection of elevated bacterial burden in wounds, with CSS.

The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.

Related company: 

Recommended for You

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.